ArticleCancer reports (Hoboken, N.J.)2023

Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer.

Kosuke Hamai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.